Charlene Young, FNP-BC

Charlene Young, FNP-BC

Professor
Neurology

    About me

    Charlene works with the Parkinson’s Center and the Dale and Deborah Smith Center for Alzheimer’s Research and Treatment and sees Parkinson’s / Movement Disorders, as well as Memory / Dementia patients. She is certified by the American Nurses Credential Center as a certified Family Nurse Practitioner.  She is a member of numerous professional organizations, including the American Academy of Nurse Practitioners. 

    Gender

    Female

    Education & training

    Positions
    Certified Nurse Practitioner
    Board Certifications
    Family Nurse Practitioner
    Medical School
    Illinois State University
    Undergraduate Degree
    Illinois State University Bloomington, IL. Masters of Science in Nursing- Family Nurse Practitioner

    Research

    Research Interests
    Parkinson's Disease, Alzheimer's Disease, Adult Neurology

    Featured Publications

    [1] Green S.  Santaolalla A.  Russell B.  George G.  Wylie H.  Monroy-Iglesias M.  Lawlor A.  Minott M.  Carty A.  Bailey V.  Green T.  Peterson Z.  Young C.  Hemelrijck MV.  Addressing health disparities and equitable representation in cancer research through the initiative, 'The Patient and Public Involvement Cancer Research Group for Diverse Backgrounds'.  2025 ;19():1885. 
    PMID: 40496318

    [2] Quinn É.  Dawson S.  Holt J.  Hossain S.  Logullo P.  O'Brien A.  Smith M.  Stewart D.  Treweek S.  Young C.  Noone C.  Moher D.  Hynes SM.  The People's Review protocol: planning an innovative study powered by the public.  2025 Mar;11(1):28. 
    PMID: 40133960

    [3] Bateman RJ.  Smith J.  Donohue MC.  Delmar P.  Abbas R.  Salloway S.  Wojtowicz J.  Blennow K.  Bittner T.  Black SE.  Klein G.  Boada M.  Grimmer T.  Tamaoka A.  Perry RJ.  Turner RS.  Watson D.  Woodward M.  Thanasopoulou A.  Lane C.  Baudler M.  Fox NC.  Cummings JL.  Fontoura P.  Doody RS.  .  Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.  2023 Nov;389(20):1862-1876. 
    PMID: 37966285

    Clinical trials

    Trial
    Neurology

    Athira: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study to Evaluate Safety and Efficacy of ATH-1017 Treatment in Alzheimer’s Dementia Patients

    Active recruiting

    ATH-1017-AD-201: The purpose of this study is to compare the effects, good or bad, of ATH-1017 on patients with mild to moderate Alzheimer's Disease.